Don't get caught out like Porky14 Mar 2022 13:18
Who based their research on Blautix, which is still important but is effectively a legacy from the pre 0518 days.
The main reason to invest here is for 0518, which is the oncology drug partnered in 2 separate programs with Merck and Pfizer.
In addition to 0518 the core priority for 4D is their 2 candidates for Parkinsons, which are expected to go into clinical trials in Q2.
Blautix is good but 0518 is the reason to invest here.